文献速递耳科与耳神经小儿耳鼻咽喉

门诊口服大环内酯类药物与儿童、青少年及青年感音神经性听力损失的关联

Association of Outpatient Oral Macrolide Use With Sensorineural Hearing Loss in Children, Adolescents, and Young Adults.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2022-01-01

该回顾性病例对照研究纳入875对匹配的儿童、青少年及青年,比较口服大环内酯类与青霉素暴露后感音神经性听力损失(SNHL)的风险。多变量分析显示,SNHL患者既往接受大环内酯类处方的比值高于青霉素(调整OR 1.31,95%CI 1.05-1.64);暴露后超过180天诊断时比值更高(调整OR 1.79,95%CI 1.23-2.60)。作者认为需进一步研究大环内酯类与SNHL的关联。

要点

  • 儿童、青少年及青年SNHL患者既往口服大环内酯类处方的比值高于青霉素(调整OR 1.31)。
  • 暴露后超过180天诊断者,大环内酯类暴露比值更高(调整OR 1.79)。
  • 作者认为需进一步研究大环内酯类与儿童、青少年及青年SNHL的关联。

核心结论

  • 在具有全国代表性的患者人群中,儿童、青少年及青年SNHL患者既往门诊口服大环内酯类处方的比值高于青霉素处方,尤其在暴露后超过180天诊断时。
  • 作者认为需进一步研究大环内酯类与儿童、青少年及青年SNHL的关联。

研究设计与样本

  • 回顾性病例对照研究,纳入875对匹配的儿童、青少年及青年,按年龄、性别和处方日期后经过时间匹配。
  • 所有符合条件的儿科患者均纳入,匹配对照来自美国TRICARE军事健康保险系统,评估时间为2009年10月1日至2014年9月30日。
  • 暴露为口服门诊大环内酯类治疗,对照为青霉素使用。
  • 采用多变量条件logistic回归比较既往大环内酯类暴露与青霉素暴露的风险,并调整其他危险因素和潜在混杂因素,另评估暴露与诊断之间的四个时间窗。

主要发现

  • 共纳入875对匹配的儿童、青少年及青年;平均(SD)年龄5.7(4.9)岁;1082名男性(62%),58名亚裔(3%),254名黑人(15%),1152名白人(66%),286名美洲原住民及其他种族和族裔(TRICARE数据库无进一步细分)(16%)。
  • 多变量分析中,当纳入暴露后所有时间窗时,SNHL患者接受大环内酯类处方相比青霉素处方的比值升高(调整OR 1.31;95%CI 1.05-1.64)。
  • 当诊断和检测发生在抗生素暴露后超过180天时,大环内酯类暴露的比值显著高于青霉素暴露(调整OR 1.79;95%CI 1.23-2.60)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Prior publications have reported the sporadic development of sensorineural hearing loss (SNHL) after intravenous or high-dose macrolide therapy for adults with comorbid conditions, but investigations of the auditory effect of oral outpatient dosing for children, adolescents, and young adults have been limited. OBJECTIVE: To determine whether broad-based outpatient use of oral macrolide therapy is associated with increased risk of pediatric SNHL through nationally representative analyses. DESIGN, SETTING, AND PARTICIPANTS: A retrospective case-control study of 875 matched pairs of children, adolescents, and young adults was performed, matching on age, sex, and the time elapsed since prescription date. All eligible pediatric patients were included, with matched control participants from the TRICARE US military health insurance system who were evaluated between October 1, 2009, and September 30, 2014. EXPOSURES: Oral outpatient macrolide treatment compared with penicillin use among pediatric patients. MAIN OUTCOMES AND MEASURES: The clinical outcome of interest was SNHL in children, adolescents, and young adults. Multivariable conditional logistic regression was used to compare the risk of prior macrolide exposure with penicillin exposure, adjusted for other risk factors and potential confounders. Four time frames between exposure and diagnosis were additionally assessed. RESULTS: There were 875 eligible matched pairs of children, adolescents, and young adults included. The mean (SD) age of the participants was 5.7 (4.9) years; 1082 participants were male (62%), 58 were Asian (3%), 254 were Black (15%), 1152 were White (66%), and 286 were of Native American and other (no further breakdown was available in the TRICARE database) race and ethnicity (16%). In multivariable analysis, participants who had SNHL had increased odds of having received a macrolide prescription compared with a penicillin prescription when all time frames from exposure were included (adjusted odds ratio, 1.31; 95% CI, 1.05-1.64). There were significantly higher odds of macrolide exposure than penicillin exposure when diagnosis and testing occurred more than 180 days after antibiotic exposure (adjusted odds ratio, 1.79; 95% CI, 1.23-2.60). CONCLUSIONS AND RELEVANCE: In this case-control study of a nationally representative patient population, findings suggest that children, adolescents, and young adults with SNHL had increased odds of outpatient oral macrolide use compared with penicillin use, particularly when having received a diagnosis more than 180 days after exposure. Further study of the association of macrolides with SNHL in children, adolescents, and young adults is warranted.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Dabekaussen KFAA, Andriotti T, Ye J, et al. Association of Outpatient Oral Macrolide Use With Sensorineural Hearing Loss in Children, Adolescents, and Young Adults. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35862062. doi:10.1001/jamaoto.2022.1293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。